ANGION
DEAD

Serial Number

88782784

Owner

Angion Biomedica Corp

Attorney

Sara M. Bauer

Filing Date

Feb 3, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ANGION Trademark

Serial Number: 88782784

ANGION is a trademark filed by Angion Biomedica Corp on February 3, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Angion Biomedica Corp (7 trademarks)

400 Kelby Street
Fort Lee, NJ 07024

Entity Type: 03

Trademark Details

Filing Date

February 3, 2020

Registration Date

Not Registered

Published for Opposition

November 17, 2020

Goods & Services

Providing a website featuring non-downloadable electronic publications in the nature of books, magazines, and brochures in the field of scientific research on heart conditions, brain conditions, kidney conditions, and liver conditions; providing a website featuring non-downloadable electronic publications in the nature of books, magazines, and brochures in the field of scientific research on ischemic conditions, fibrosis, autoimmune diseases, organ transplantation; providing a website featuring non-downloadable electronic publications in the nature of books, magazines, and brochures in the field of related to scientific research on acute organ injuries

Downloadable electronic publications in the nature of books, magazines, and brochures in the field of scientific research on heart conditions, brain conditions, kidney conditions, and liver conditions; downloadable electronic publications in the nature of books, magazines, and brochures in the field of scientific research on ischemic conditions, fibrosis, autoimmune diseases, organ transplantation; downloadable electronic publications in the nature of books, magazines, and brochures in the field of scientific research on acute organ injuries

Small molecule therapeutic pharmaceuticals for the treatment, alleviation and prevention of acute organ injuries and fibrotic diseases; pharmaceutical and biological preparations for the treatment, alleviation and prevention of heart conditions, brain conditions, kidney conditions, and liver conditions; pharmaceutical and biological preparations for use in the treatment, alleviation and prevention of ischemic conditions; pharmaceutical and biological preparations for use in the treatment, alleviation and prevention of fibrosis; pharmaceutical and biological preparations for use in the treatment, alleviation and prevention of autoimmune diseases; pharmaceutical and biological preparations for use in the treatment, alleviation and prevention of delayed graft function and acute kidney injury

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 13, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 13, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 12, 2022 EXRA
SOU EXTENSION 3 GRANTED
Jul 8, 2022 EX3G
SOU EXTENSION 3 FILED
Jul 8, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 8, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 13, 2022 EXRA
SOU EXTENSION 2 GRANTED
Jan 11, 2022 EX2G
SOU EXTENSION 2 FILED
Jan 11, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 11, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 13, 2021 EXRA
SOU EXTENSION 1 GRANTED
Jul 9, 2021 EX1G
SOU EXTENSION 1 FILED
Jul 9, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 9, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 12, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 17, 2020 NPUB
PUBLISHED FOR OPPOSITION
Nov 17, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 28, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 15, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 14, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 14, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 14, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 22, 2020 GNRN
NON-FINAL ACTION E-MAILED
Apr 22, 2020 GNRT
NON-FINAL ACTION WRITTEN
Apr 22, 2020 CNRT
ASSIGNED TO EXAMINER
Apr 22, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 6, 2020 NWOS
NEW APPLICATION ENTERED
Feb 6, 2020 NWAP